Bay Colony Advisory Group, Inc D Astrazeneca PLC Transaction History
Bay Colony Advisory Group, Inc D
- $634 Million
- Q3 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Astrazeneca PLC stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 21,581 shares of AZN stock, worth $1.4 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
21,581
Previous 20,881
3.35%
Holding current value
$1.4 Million
Previous $1.63 Million
3.26%
% of portfolio
0.26%
Previous 0.28%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,347Shares Held
491MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.2 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$2.76 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...